title: Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?
authors.forename: Christoph U
authors.initials: CU
authors.lastname: Correll
authors.forename: Linmarie
authors.initials: L
authors.lastname: Sikich
authors.forename: Gloria
authors.initials: G
authors.lastname: Reeves
authors.forename: Mark
authors.initials: M
authors.lastname: Riddle
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008659:Metabolic Diseases / Q000188:drug therapy*; D008687:Metformin; D009765:Obesity / Q000188:drug therapy*; D011618:Psychotic Disorders; D012559:Schizophrenia; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D008687:Metformin